Australia's largest stock trading and investment forum Australia's #1 stock forum

RNO

Click for more information

0.00%

4.0¢ rhinomed limited

Ann: September Update, page-12

First 12 Last

Share
Profile

Follow
davship

327 Posts.

44

20/09/18

11:16

Post #: 35721935
Share

Originally posted by Chillicop ↑

Some more on the above from http://www.investing.businessweek.w...asp?personId=226982114&privcapId=35411569

Mr. Michael Johnson serves as the Chief Executive Officer and Managing Director of Rhinomed Limited (formerly, Consegna Group Limited) and has been its Executive Director since February 1, 2013. Mr. Johnson serves as a Director of Melbourne based Cogentum. His experience includes advising the team at Acrux (ASX:ACR) as they successfully licensed the Axiron® product with Eli Lilly, the largest biotech licensing deal in Australia at the time and CogState (ASX:CGS) as they effectively entered the sport concussion market. Mr. Johnson has held senior roles with some of the world's most successful marketing and communication firms where he has successfully launched a number of high profile new products and brands.

Dewhurst and US / Canadian Sub. shareholders - not in here for fun that's for sure .. cross fingers and hang on IMO

Expand

Great article, loving he's success rate, let's hope he can negotiate big things for RNO

RNO Price at posting: 23.0¢ Sentiment: Buy Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

CPV

ClearVue inks deal with UK heated glass player to combine solar tech with its offering

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

AR3

Overland drilling proves promising for Australian Rare Earths' uranium hopes

3DA

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

Trump is President Again: What Does This Mean for Crypto?

There are more pages in this discussion • 6 more messages in this thread...

First 12 Last

Add RNO (ASX) to my watchlist